On Dec. 23, Solventum completed its acquisition of Acera Surgical, a bioscience company that developed and commercialized fully engineered materials for regenerative wound care. Solventum, which had announced a definitive agreement to acquire Acera in November, is paying $725 million in cash plus up to $125 million in contingent cash…
Free Daily News